Northern Trust Corp Halozyme Therapeutics, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 1,682,154 shares of HALO stock, worth $79 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,682,154

Previous 1,796,035 6.34%

Holding current value

$79 Million

Previous $94 Million 2.34%

% of portfolio

0.02%

Previous 0.02%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$51.3 - $64.42 $5.84 Million - $7.34 Million	-113,881 Reduced 6.34%	1,682,154 $96.2 Million
Q2 2024 Aug 14, 2024	BUY	$37.81 - $52.4 $156,193 - $216,464	4,131 Added 0.23%	1,796,035 $94 Million
Q1 2024 May 14, 2024	SELL	$33.68 - $41.95 $6.12 Million - $7.63 Million	-181,840 Reduced 9.21%	1,791,904 $72.9 Million
Q4 2023 Feb 13, 2024	SELL	$33.32 - $42.1 $1.15 Million - $1.45 Million	-34,412 Reduced 1.71%	1,973,744 $72.9 Million
Q3 2023 Nov 13, 2023	SELL	$36.46 - $44.03 $548,941 - $662,915	-15,056 Reduced 0.74%	2,008,156 $76.7 Million
Q2 2023 Aug 11, 2023	SELL	$30.28 - $38.74 $20,529 - $26,265	-678 Reduced 0.03%	2,023,212 $73 Million
Q1 2023 May 15, 2023	SELL	$32.86 - $55.7 $2.13 Million - $3.62 Million	-64,952 Reduced 3.11%	2,023,890 $77.3 Million
Q4 2022 Feb 13, 2023	SELL	$40.06 - $59.44 $1.17 Million - $1.74 Million	-29,280 Reduced 1.38%	2,088,842 $119 Million
Q3 2022 Nov 14, 2022	SELL	$38.53 - $51.78 $1.38 Million - $1.85 Million	-35,820 Reduced 1.66%	2,118,122 $83.8 Million
Q2 2022 Aug 12, 2022	SELL	$37.35 - $48.3 $3.36 Million - $4.35 Million	-90,059 Reduced 4.01%	2,153,942 $94.8 Million
Q1 2022 May 13, 2022	SELL	$31.97 - $41.06 $1.82 Million - $2.34 Million	-56,972 Reduced 2.48%	2,244,001 $89.5 Million
Q4 2021 Feb 08, 2022	SELL	$31.82 - $40.75 $1.35 Million - $1.73 Million	-42,560 Reduced 1.82%	2,300,973 $92.5 Million
Q3 2021 Nov 15, 2021	BUY	$38.47 - $46.42 $690,382 - $833,053	17,946 Added 0.77%	2,343,533 $95.3 Million
Q2 2021 Aug 13, 2021	BUY	$38.84 - $51.31 $3.31 Million - $4.38 Million	85,308 Added 3.81%	2,325,587 $106 Million
Q1 2021 May 12, 2021	SELL	$39.51 - $51.45 $131,054 - $170,659	-3,317 Reduced 0.15%	2,240,279 $93.4 Million
Q4 2020 Feb 11, 2021	BUY	$25.81 - $43.62 $6.08 Million - $10.3 Million	235,691 Added 11.74%	2,243,596 $95.8 Million
Q3 2020 Nov 16, 2020	SELL	$25.74 - $29.63 $1.63 Million - $1.88 Million	-63,400 Reduced 3.06%	2,007,905 $52.8 Million
Q2 2020 Aug 14, 2020	BUY	$16.25 - $26.81 $2.45 Million - $4.04 Million	150,547 Added 7.84%	2,071,305 $55.5 Million
Q1 2020 May 14, 2020	SELL	$13.9 - $21.83 $814,345 - $1.28 Million	-58,586 Reduced 2.96%	1,920,758 $34.6 Million
Q4 2019 Feb 14, 2020	SELL	$14.93 - $19.53 $392,375 - $513,267	-26,281 Reduced 1.31%	1,979,344 $35.1 Million
Q3 2019 Nov 13, 2019	BUY	$15.2 - $17.69 $3.27 Million - $3.81 Million	215,150 Added 12.02%	2,005,625 $31.1 Million
Q2 2019 Aug 13, 2019	BUY	$14.75 - $17.26 $123,560 - $144,587	8,377 Added 0.47%	1,790,475 $30.8 Million
Q1 2019 May 13, 2019	BUY	$13.94 - $17.58 $190,225 - $239,896	13,646 Added 0.77%	1,782,098 $28.7 Million
Q4 2018 Feb 12, 2019	SELL	$13.33 - $18.66 $707,476 - $990,360	-53,074 Reduced 2.91%	1,768,452 $25.9 Million
Q3 2018 Nov 14, 2018	SELL	$16.68 - $18.41 $325,827 - $359,620	-19,534 Reduced 1.06%	1,821,526 $33.1 Million
Q2 2018 Sep 18, 2018	SELL	$16.87 - $20.3 $152,116 - $183,045	-9,017 Reduced 0.49%	1,841,060 $31.1 Million
Q2 2018 Aug 14, 2018	BUY	$16.87 - $20.3 $3.25 Million - $3.91 Million	192,497 Added 11.61%	1,850,077 $31.2 Million
Q1 2018 May 09, 2018	BUY	$17.06 - $21.2 $108,928 - $135,362	6,385 Added 0.39%	1,657,580 $32.5 Million
Q4 2017 Feb 14, 2018	SELL	$16.75 - $20.8 $986,776 - $1.23 Million	-58,912 Reduced 3.44%	1,651,195 $33.5 Million
Q3 2017 Nov 13, 2017	BUY	$11.76 - $17.4 $20.1 Million - $29.8 Million	1,710,107	1,710,107 $29.7 Million

Others Institutions Holding HALO

# of Institutions

543

Shares Held

125M

Call Options Held

294K

Put Options Held

180K

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.54B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Halozyme Therapeutics, Inc. Transaction History